SCHEMBL20075918

SCHEMBL20075918

NC1CCN(CCOI)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 1/20 0.46
▸ GNAO1 P09471 1/20 0.46
▸ GNAI1 P63096 1/20 0.46
▸ HRH3 Q9Y5N1 4/20 0.39
▸ HRH2 P25021 3/20 0.39
▸ HRH1 P35367 3/20 0.39
▸ SPHK1 Q9NYA1 1/20 0.37
▸ LTA4H P09960 4/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ SIGMAR1 Q99720 2/20 0.33
▸ TMEM97 Q5BJF2 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20463262 0.79 GNAI3 (0.47) GNAI3GNAO1GNAI1HRH3HRH2
SCHEMBL14385014 0.78 CARM1 (0.50) HRH3SIGMAR1KDM4ECYP1A2CYP2D6
SCHEMBL1957601 0.78 GNAI3 (0.50) GNAI3GNAO1GNAI1HRH3HRH2
SCHEMBL18539756 0.75 GNAI3 (0.56) GNAI3GNAO1GNAI1HRH3HRH2
SCHEMBL6942292 0.75 GNAI3 (0.47) GNAI3GNAO1GNAI1HRH3HRH2
SCHEMBL23158206 0.75 NPC1 (0.38) HRH3LTA4HNPC1SIGMAR1TMEM97
SCHEMBL25864036 0.74 — —
SCHEMBL22297529 0.74 GNAI3 (0.46) GNAI3GNAO1GNAI1HRH3HRH2
SCHEMBL27575307 0.74 GNAI3 (0.42) GNAI3GNAO1GNAI1HRH3HRH2
SCHEMBL13668229 0.74 GNAI3 (0.46) GNAI3GNAO1GNAI1HRH3HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024020221-A1 MODULATORS OF TYK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-01-25 — — WO disclosed
EP-3689868-B1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS ARVINAS OPERATIONS INC (US) 2023-09-27 — — EP disclosed
EP-3660004-B1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR ARVINAS OPERATIONS INC (US) 2023-02-22 — — EP disclosed
WO-2021067606-A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2021-04-08 — — WO disclosed
WO-2018118598-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF FETAL LIVER KINASE POLYPEPTIDES Arvinas, Inc. (US) 2018-06-28 — — WO disclosed
WO-2018102725-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas, Inc. (US) 2018-06-07 — — WO disclosed
WO-2018071606-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas, Inc. (US) 2018-04-19 — — WO disclosed
Send feedback